UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000012452
Receipt No. R000014567
Scientific Title Phase II Trial of Pertuzumab plus Trastuzumab plus Docetaxel for HER2-Positive Metastatic Breast Cancer that Progressed During Prior Trastuzumab Therapy
Date of disclosure of the study information 2013/12/02
Last modified on 2018/12/04 00:49:32

No. Disposal Last modified on Item of update
1 Insert 2013/12/01 18:45:10
2 Update 2015/01/15 02:26:25 Last name of contact person
Last name of contact person
Division name
Division name
Email
3 Update 2018/12/04 00:49:32 Recruitment status


Contact us.